Eric Benevich

2018

In 2018, Eric Benevich earned a total compensation of $3.7M as Chief Commercial Officer at Neurocrine Biosciences, a 23% increase compared to previous year.

Compensation breakdown

Bonus$205,485
Option Awards$1,496,335
Salary$432,600
Stock Awards$1,499,417
Other$38,768
Total$3,672,605

Benevich received $1.5M in stock awards, accounting for 41% of the total pay in 2018.

Benevich also received $205.5K in bonus, $1.5M in option awards, $432.6K in salary and $38.8K in other compensation.

Rankings

In 2018, Eric Benevich's compensation ranked 3,072nd out of 14,244 executives tracked by ExecPay. In other words, Benevich earned more than 78.4% of executives.

ClassificationRankingPercentile
All
3,072
out of 14,244
78th
Division
Manufacturing
1,138
out of 5,765
80th
Major group
Chemicals And Allied Products
392
out of 2,128
82nd
Industry group
Drugs
322
out of 1,817
82nd
Industry
Biological Products, Except Diagnostic Substances
71
out of 339
79th

Pay ratio

Eric Benevich's Pay$3,672,605
Median Employee's Pay$259,000
Pay Ratio

14

to 1

In 2018, the annual total compensation of Eric Benevich was $3,672,605.

The annual total compensation of the median employee at Neurocrine Biosciences was $259,000.

The ratio of Eric Benevich's pay to the pay of median employee was therefore 14 to one.

Source: SEC filing on April 17, 2019.

Benevich's colleagues

We found five more compensation records of executives who worked with Eric Benevich at Neurocrine Biosciences in 2018.

2018

Kevin Gorman

Neurocrine Biosciences

Chief Executive Officer

2018

Eiry Roberts

Neurocrine Biosciences

Chief Medical Officer

2018

Kyle Gano

Neurocrine Biosciences

Chief Business Development Officer

2018

Haig Bozigian

Neurocrine Biosciences

Chief Development Officer

2018

Matthew Abernethy

Neurocrine Biosciences

Chief Financial Officer

News

You may also like